Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Quitting before the knife: which Stop-Smoking aid works best for cancer patients?

NCT ID NCT04899492

Disease control Sponsor: Institut Cancerologie de l'Ouest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial explores whether adding counseling, cognitive behavioural therapy, or hypnotherapy to nicotine replacement therapy can help cancer patients quit smoking before their surgery. The study includes adults with breast, digestive, gynecologic cancer, or melanoma who smoke daily and want to quit. Participants receive nicotine replacement and may also be assigned to one of the extra support options. The main goal is to see if these programs are practical and acceptable for patients preparing for surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nicotine replacement therapy, motivational interviewing, cognitive behavioural therapy, or hypnotherapy
What this could lead to
If successful, this could identify practical ways to help cancer patients quit smoking before surgery, potentially improving recovery and long-term health.
What could go wrong
This is a small pilot study focused on feasibility, so it may not prove which approach works best. Some patients may find the therapies difficult or not complete them.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

21 people

The number who actually took part.

Started

Sep 2021

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years. * Smoking patient: daily tobacco consumption. * Patient with cancer requiring surgical treatment (breast cancer, digestive cancer, gynecological). * Patient wishing to quit smoking. * Fagerström \> 3. * Patient has valid health insurance * Information and agreement of the patient to participate in the longitudinal cohort. * Signing of specific informed consent for patients in groups 1 to 4 before any study-related intervention. * Person able to speak, read and understand French. Exclusion Criteria: * Patient not receiving surgical treatment. * Refusal to participate in the longitudinal cohort study. * Pregnant or likely to be pregnant or nursing patient. * Persons deprived of their liberty, under a measure of safeguard of justice, under guardianship or placed under the authority of a guardian * disability to undergo the medical follow-up of the trial for geographical, social or psychological reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm digestive system cancer digestive system neoplasm female reproductive organ cancer melanoma Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Digestive cancer Gynecologic cancer Melanoma

Contacts and locations

Locations

  • Institut de Cancerologie de l'Ouest (ICO)

    Saint-Herblain, 44805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.